| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233850 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 9 Pages |
Abstract
Metastatic involvement of the limbic circuit is uncommon and limited primarily to patients with nonoligometastatic disease, supporting our hypothesis that it is reasonable to selectively exclude or reduce the dose to the limbic circuit when treating patients with prophylactic cranial irradiation or whole-brain radiotherapy for oligometastatic disease not involving these structures.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
James C. M.D., Arnold M. M.D., Benjamin T. M.D., Frank F. Ph.D., Thomas Ph.D., Julius Ph.D., Ross A. M.D.,